Delynov Chirurgie, Delynov Endocarditis: the fulminant expansion of a pre-existing cerebral aneurysm In the context of infective endocarditis (IE), the development of infectious intracranial aneurysms (IIA) is typically described as a de novo phenomenon resulting from embo... Jan 15, 2026
Delynov Chirurgie, Delynov Percutaneous tricuspid replacement: the major asset for massive regurgitation Functional tricuspid regurgitation, long undertreated, exposes patients to a deleterious cascade: right heart failure, systemic congestion, and excess mortality. Jan 12, 2026
Delynov Chirurgie, Delynov Mitral valve repair: durable success in primary, higher risks in functional Mitrale valve repair has become the gold standard treatment for mitral regurgitation (MR), though its actual impact on cardiac remodeling remains complex to a... Jan 12, 2026
Delynov Chirurgie, Delynov Minimally Invasive Mitral Surgery: Heart Team Reduces Stays and Complications Minimally invasive mitral surgery (MIS) via right mini-thoracotomy has emerged as an effective alternative to median sternotomy, offering accelerated recovery and improved clinical outcomes. Jan 9, 2026
Delynov Chirurgie, Delynov M-TEER: a renal resistance index > 0.70 predicts mortality In the management of severe mitral regurgitation (MR) in high-risk surgical patients, rigorous selection of candidates for Mitral Transcatheter Edge-to-Edge Repair (M-TEER) is essential. This article details the clinical and anatomical criteria required to optimize procedural success. Jan 8, 2026
Delynov Chirurgie, Delynov TEER and mitral regurgitation: an effective bridge to heart transplantation? Advanced heart failure (HF), when complicated by significant secondary mitral regurgitation (MR), imposes a poor prognosis. While cardiac transplantation... Jan 7, 2026
Delynov Chirurgie, Delynov Mitral valve repair: 95% freedom from reintervention at 5 years with Memo 3D/4D In mitral valve repair, precise sizing of artificial chordae length is a critical and technically demanding step. The Memo 3D/4D ReChord system has been... Jan 5, 2026
Delynov Chirurgie, Delynov MICS: 30 years of technical progress in cardiac surgery Minimally Invasive Cardiac Surgery (MICS) is no longer a niche approach, now representing one third of cardiac procedures worldwide. Defined by the absence of... Jan 4, 2026
Delynov Chirurgie, Delynov MitraClip: Addressing Iatrogenic Leaflet and Chordal Injuries Transcatheter edge-to-edge repair (TEER) has established itself as the gold standard treatment for severe primary or secondary mitral regurgitation (MR) in pati... Jan 1, 2026
Delynov Chirurgie, Delynov Parachute mitral valve: the challenge of replacement in adults Parachute mitral valve (PMV) is a rare congenital anomaly characterized by the insertion of all chordae tendineae into a single papillary muscle, causing... Jan 1, 2026
Delynov Chirurgie, Delynov ASD Repair: Left Atrial Size Predicts Mitral Regurgitation Worsening While surgical closure of an ostium secundum atrial septal defect (ASD) aims for haemodynamic restoration, the progression of associated mitral regurgitation (MR)... Jan 1, 2026
Delynov Chirurgie, Delynov Mitral valve repair: CT for sizing rings and loops in 34 patients In minimally invasive mitral surgery, the precision of prosthetic sizing is a major determinant of residual valvular competence. The selection of the long... Jan 1, 2026